Diagnostic performance of Xpert-based assays for spinal tuberculosis: a systematic review and diagnostic accuracy meta-analysis
Frontiers in Cellular and Infection Microbiology · 06.11.2026 · 16
DOI: 10.3389/fcimb.2026.1916158 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 06.11.2026. Verfasst von Jian Ye und 6 weiteren Autor:innen. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Spinal tuberculosis is a severe form of extrapulmonary tuberculosis that often results in delayed diagnosis and irreversible neurological complications. Xpert MTB/RIF and Xpert MTB/RIF Ultra have been developed as rapid molecular diagnostic tools; however, their diagnostic performance in spinal tuberculosis remains uncertain, particularly across different reference standards.
Objective
To systematically evaluate the diagnostic accuracy of Xpert-based assays for spinal tuberculosis and assess the influence of different reference standards on pooled diagnostic estimates.
Methods
A systematic search of PubMed, Embase, Web of Science, and the Cochrane Library was performed from database inception to June 2026. Studies evaluating Xpert MTB/RIF or Xpert MTB/RIF Ultra in patients with suspected spinal tuberculosis and providing sufficient data to construct 2×2 diagnostic tables were included. Pooled sensitivity, specificity, likelihood ratios, and diagnostic odds ratios were estimated using a bivariate random-effects model. Hierarchical summary receiver operating characteristic (HSROC) curves were generated. The primary analysis included studies using composite or clinical reference standards, whereas mycobacterial culture alone was evaluated in a separate sensitivity analysis.
Results
Twelve studies were included in the quantitative synthesis. In the primary analysis based on composite or clinical reference standards, the pooled sensitivity and specificity of Xpert-based assays were 0.77 (95% CI: 0.66–0.86) and 1.00 (95% CI: 0.99–1.00), respectively. The pooled positive and negative likelihood ratios were 43.86 (95% CI: 23.65–81.36) and 0.24 (95% CI: 0.15–0.37), respectively, with a diagnostic odds ratio of 213.28 (95% CI: 89.30–509.42). In the sensitivity analysis using mycobacterial culture as the reference standard, pooled sensitivity increased to 0.94 (95% CI: 0.88–0.98), whereas specificity decreased to 0.62 (95% CI: 0.44–0.78). Only one included study evaluated Xpert MTB/RIF Ultra, limiting conclusions regarding its comparative performance.
Conclusion
Xpert-based assays demonstrate high diagnostic accuracy for spinal tuberculosis, particularly strong confirmatory capability due to high specificity. However, negative results alone are insufficient to exclude disease. The choice of reference standard substantially influences pooled diagnostic estimates, highlighting the importance of interpreting Xpert results together with clinical, radiological, microbiological, and histopathological findings. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420261427181 , identifier CRD420261427181.
Zitieren
APA
Ye, J., Zhang, L., Xue, C., Liao, M., Chen, X., Lu, C., & Wang, L. (2026). Diagnostic performance of Xpert-based assays for spinal tuberculosis: a systematic review and diagnostic accuracy meta-analysis. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1916158
Vancouver
Ye J, Zhang L, Xue C, Liao M, Chen X, Lu C, et al. Diagnostic performance of Xpert-based assays for spinal tuberculosis: a systematic review and diagnostic accuracy meta-analysis. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1916158
BibTeX
@article{Ye2026,
author = {Ye, Jian and Zhang, Libao and Xue, Changhui and Liao, Mingxin and Chen, Xiaojun and Lu, Chengwu and Wang, Linfeng},
title = {Diagnostic performance of Xpert-based assays for spinal tuberculosis: a systematic review and diagnostic accuracy meta-analysis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1916158}
}
EUVIMED